CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Volumn 10, Issue 5-6, 2009, Pages 487-489

  Van Rooij, Frank G ^a   Schelhaas, H Jurgen ^a,b   Lammers, Gert Jan ^c   Verbeek, Marcel M ^a   Overeem, Sebastiaan ^a,c  

^a RADBOUD UNIVERSITY   (Netherlands)

^b National ALS Centre   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amyotrophic lateral sclerosis; Cerebrospinal fluid; Hypocretin; Orexin; Sleep disorders

Indexed keywords

OREXIN A;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; LUMBAR PUNCTURE; MALE; PRIORITY JOURNAL; SAMPLE; SYMPTOM;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEUROPEPTIDES; SLEEP;

EID: 70450179512     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482960802315024     Document Type: Article

References (18)

1. Hammad M, Silva A, Glass J, Sladky JT, Benatar M. Clinical, electrophysiological, and pathological evidence for sensory abnormalities in ALS. Neurology. 2007;69:2236-42.
2. Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6:994-1003. (Pubitemid 47562321)
3. Baltadzhieva R, Gurevich T, Korczyn AD. Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol. 2005;18:487-93.
4. Beck M, Giess R, Magnus T, Puls I, Reiners K, Toyka KV, et al. Progressive sudomotor dysfunction in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2002;73:68-70. (Pubitemid 34713017)
5. Toepfer M, Folwaczny C, Klauser A, Riepl RL, Muller-Felber W, Pongratz D. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 1999;1:15-9.
6. Culebras A. Sleep and neuromuscular disorders. Neurol Clin. 1996;14:791-805.
7. Hetta J, Jansson I. Sleep in patients with amyotrophic lateral sclerosis. J Neurol. 1997;244:S7-9.
8. Sforza E, Krieger J, Petiau C. REM sleep behaviour disorder: clinical and physiopathological findings. Sleep Med Rev. 1997;1:57-69.
9. Thomas A, Bonanni L, Onofrj M. Symptomatic REM sleep behaviour disorder. Neurol Sci. 2007;28(Suppl 1):S21-36.
10. Baumann CR, Bassetti CL. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter. Sleep Med Rev. 2005;9:253-68.
11. Eggermann E, Serafin M, Bayer L, Machard D, Saint-Mleux B, Jones BE, et al. Orexins/hypocretins excite basal forebrain cholinergic neurons. Neuroscience. 2001;108:177-81.
12. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 1998;18:9996-10015.
13. Yamuy J, Fung SJ, Xi M, Chase MH. Hypocretinergic control of spinal cord motor neurons. J Neurosci. 2004;24: 5336-45.
14. Aziz A, Fronczek R, Maat-Schieman M, Unmehopa U, Roelandse F, Overeem S, et al. Hypocretin and melaninconcentrating hormone in patients with Huntington's disease. Brain Pathol. 2008. Published online 22 May 2008.
15. Fronczek R, Overeem S, Lee SY, Hegeman IM, van Pelt J, van Duinen SG, et al. Hypocretin (orexin) loss in Parkinson's disease. Brain. 2007;130:1577-85.
16. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293-9.
17. Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 2002;59:1553-62.
18. Gerashchenko D,Murillo-Rodriguez E, Lin L, Xu M, Hallett L, Nishino S, et al. Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol. 2003; 184:1010-6.